ESMO Deep Dive: Lung Cancer

ESMO Deep Dive: Lung Cancer

Series Coordinator: Natasha Leighl

This new webinar series provides oncologists, who already possess a solid foundation in the diagnostic approach, risk assessment, and treatment of lung cancer patients, with an enhanced educational experience that delves into emerging data covering:

• Molecular biology and classification
• Translational research and biomarkers in precision medicine
• Areas of uncertainty, hypotheses, and current research concerning controversial issues or unmet needs in optimal patient management 

By the end of the series, healthcare professionals will:

• Gain a more comprehensive understanding of the disease's clinical progression, biological theories related to classification and risk stratification, and the ongoing and necessary research in therapeutics, including the use of omics technologies for biomarker-driven precision medicine.
• Enhance their skills in critically analysing and interpreting research data and therapeutic approaches.
• Be better prepared to engage in innovative thinking and to participate in ongoing or new research initiatives.

Programme 2025:

February - Precision Oncology in Lung Cancer

March - Non-metastatic NSCLC: Multidisciplinary State of the Art

April - Advanced NSCLC: Non-oncogene Addicted (ADCs, Immunotherapy, Microbiome)

May - Advanced NSCLC – EGFR, RAS/RAF, MET, ERBB2

June - Advanced NSCLC -  ALK, ROS1, TRK, RET

July - Oligometastases: Current approaches

September - Small Cell Lung Cancer

October - Thymic carcinoma, Mesothelioma, Thoracic NETs

November - Lung Cancer Risks and Survivorship

Every webinar provides a chance for live interaction between the audience and the experts.

Live viewers of the webinars will be awarded a certificate of attendance and 2 ESMO-MORA category 1 points for each webinar.

The recordings are available to all ESMO Members a few days after the live event.